Hi, How Are You?
↻
Let's Get Started
Forgot Password?
Sign Up
EN
Home
Article
Events
All Events
Webinar
new!
Product & Disease
Product
Disease
Pharmacovigilance
Medical Calculator
new!
Education
MOOC
CDK
Multimedia
FAQ & Feedback
Discussions
About Us
Login
Register
Product
Profile
PRODUCTS
DISEASE
PHARMACOVIGILANCE
MEDCAL
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
KALFOXIM
BRANDED
Parenteral 3rd generation cephalosporin. Inhibiting Penicillin Binding Bacterial proteins then inhibit bacterial cell wall synthesis so that it is bactericidal.
Available at :
Share this article
Related
Articles
Tripledemic Alert, 3 Concurrent Respiratory Infections
by dr. Dita Arccinirmala | 20 May 2025
.
by dr. Desta Wulan Restu | 11 Sep 2024
'Mysterious' Pneumonia in China, These are the Facts
by dr. Vivian Keung | 01 Dec 2023
Antimicrobial Misuse and Resistance
by dr. Vivian Keung | 18 Nov 2023
.
by dr. Johan Indra Lukito | 11 Aug 2023
Update on the CDC Guidelines for the Treatment of Gonococcal Infections (Gonorrhea) in 2020
by dr. Johan Indra Lukito | 03 Oct 2022
Administration of Levofloxacin Reduces the Risk of Death in Pneumonia Caused by Stenotrophomonas maltophilia
by dr. Lyon Clement | 05 May 2022
Meta-analysis, Use of Dexmedetomidine vs Propofol in Sepsis Patients With Ventilator
by dr. Laurencia Ardi | 27 Dec 2021
Fluoroquinolones in COVID-19 Therapy, what is the role?
by dr. Della Sulamita | 14 Jul 2021
Macrolide Antibiotics in Chronic Respiratory Diseases, What Are the Recommendations for Its Use?
by dr. Della Sulamita | 29 Apr 2021
×
Subscribe Status
Generals
Articles
CPD/CME & CDK
Events & Webinar
SAVE